Oncopharmpod
Q 6 Pembro, PARP Inhibitors, MonarcHER, Griffin
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:25:14
- Mas informaciones
Informações:
Sinopsis
Topics of discussion: Q 6 week pembrolizumab dosing schedule FDA approved Updates on possible PARP inhibitor use. Niraparib for ovarian maintenance. Olaparib in prostate cancer (5:28) The monarcHER study of abemaciclib in HER+ MBC (12:20) The GRIFFIN study of Dara+VRD in myeloma (17:00)
